Intersouth Partners

Total investments

164

Average round size

13M

Portfolio companies

72

Rounds per year

4.10

Lead investments

18

Follow on index

0.56

Exits

37

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyHealth CareEnterprise SoftwareMedical DeviceMedicalPharmaceuticalTherapeutics

Summary

In 1984 was created Intersouth Partners, which is appeared as VC. The leading representative office of defined VC is situated in the Durham. The venture was found in North America in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Biolex Therapeutics, 480 Biomedical, MicroCHIPS We can highlight the next thriving fund investment areas, such as Enterprise Software, Information Technology.

The overall number of key employees were 2.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 7-12 deals per year. The increased amount of exits for fund were in 2010. Opposing the other organizations, this Intersouth Partners works on 7 percentage points less the average amount of lead investments. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies. The average startup value when the investment from Intersouth Partners is 1-5 millions dollars. The important activity for fund was in 2007. Despite it in 2019 the fund had an activity.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Intersouth Partners, startups are often financed by Harbert Growth Partners, Alliance Technology Ventures, Skyline Ventures. The meaningful sponsors for the fund in investment in the same round are Skyline Ventures, Noro-Moseley Partners, H.I.G. Capital. In the next rounds fund is usually obtained by Grotech Ventures, The Aurora Funds, TVM Capital.

Show more

Investments analytics

Analytics

Total investments
164
Lead investments
18
Exits
37
Rounds per year
4.10
Follow on index
0.56
Investments by industry
  • Biotechnology (72)
  • Health Care (57)
  • Software (42)
  • Enterprise Software (31)
  • Medical (26)
  • Show 82 more
Investments by region
  • United States (164)
Peak activity year
2007

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
18M
Group Appearance index
0.93
Avg. company exit year
15
Avg. multiplicator
0.42
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
AirBound 11 Aug 2021 Seed 25K
Arsenal Medical 28 Sep 2007 Biotechnology, Health Care, Medical Device, Therapeutics Early Stage Venture 13M United States, Massachusetts
Cashlink 31 Oct 2022 Venture Capital, Financial Services, FinTech, Cryptocurrency Seed Hesse, Frankfurt, Germany
Vascular Pharmaceuticals 12 Sep 2012 Biotechnology, Health Care, Diabetes Early Stage Venture 16M United States, North Carolina

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.